Vancouver, Canada, Jan. 07, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the “Company”), a clinical-stage biotech company focused on discovery...
Vancouver, Canada, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery...
TEL AVIV, Israel, Jan. 06, 2025 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) ("Company" or "SciSparc"), a specialty clinical-stage pharmaceutical company focusing on the development of...
Vancouver, Canada, Jan. 02, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery...
Company recently signed a non-binding term sheet with Dr Glitter Pty Ltd for mutual development in ActivCrystal™ Format Vancouver, Canada, Dec. 26, 2024 (GLOBE NEWSWIRE) -- Clearmind Medicine...
Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.1387 | -9.30872483221 | 1.49 | 1.51 | 1.35 | 101313 | 1.38110503 | CS |
4 | -0.125 | -8.46711373027 | 1.4763 | 1.75 | 1.35 | 172657 | 1.499277 | CS |
12 | -0.0487 | -3.47857142857 | 1.4 | 2.18 | 1.14 | 1146128 | 1.67831483 | CS |
26 | -0.3387 | -20.0414201183 | 1.69 | 2.18 | 1.06 | 694070 | 1.59156158 | CS |
52 | -0.0287 | -2.07971014493 | 1.38 | 2.3 | 0.9512 | 1200360 | 1.57341151 | CS |
156 | -161.2487 | -99.1689421894 | 162.6 | 183 | 0.9205 | 1246231 | 8.27151449 | CS |
260 | -161.2487 | -99.1689421894 | 162.6 | 183 | 0.9205 | 1246231 | 8.27151449 | CS |
Symbole | Prix | Vol. |
---|---|---|
TCTMTCTM Kids IT Education Inc | US$ 0,764 (321,87%) | 731,1M |
NVDANVIDIA Corporation | US$ 120,07 (-3,67%) | 388,5M |
RIMEAlgorhythm Holdings Inc | US$ 0,02565 (5,12%) | 341,8M |
CLEUChina Liberal Education Holdings Ltd | US$ 0,1938 (30,77%) | 237,15M |
BHATBlue Hat Interactive Entertainment Technology | US$ 0,0355 (-11,25%) | 236,44M |
Aucune Discussion Trouvée |
Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales